|
LOC652276 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.13280000000071E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.753000E-04 |
| Normal-vs-Stage2 |
1.154010E-02 |
| Normal-vs-Stage3 |
2.33510000002823E-06 |
| Normal-vs-Stage4 |
1.398450E-03 |
| Stage1-vs-Stage2 |
9.897600E-01 |
| Stage1-vs-Stage3 |
3.454300E-02 |
| Stage1-vs-Stage4 |
4.577400E-01 |
| Stage2-vs-Stage3 |
1.402210E-01 |
| Stage2-vs-Stage4 |
5.542000E-01 |
| Stage3-vs-Stage4 |
4.187000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.80240000000299E-05 |
| Normal-vs-AfricanAmerican |
2.066400E-02 |
| Normal-vs-Asian |
1.089730E-02 |
| Caucasian-vs-AfricanAmerican |
9.891800E-01 |
| Caucasian-vs-Asian |
5.418200E-01 |
| AfricanAmerican-vs-Asian |
6.680800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.26679999995694E-06 |
| Normal-vs-Female |
3.016400E-04 |
| Male-vs-Female |
9.665800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.799040E-03 |
| Normal-vs-Age(41-60Yrs) |
1.94546999999767E-05 |
| Normal-vs-Age(61-80Yrs) |
1.696200E-03 |
| Normal-vs-Age(81-100Yrs) |
6.504400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.191400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.700600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.331770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.758800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.986600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.924360E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.543200E-01 |
| Classical-VS-Follicular |
6.862000E-02 |
| Classical-VS-Other |
3.589200E-01 |
| Classical-VS-Normal |
5.190400E-04 |
| Tall-VS-Follicular |
5.395400E-01 |
| Tall-VS-Other |
5.890800E-01 |
| Tall-VS-Normal |
9.303200E-03 |
| Follicular-VS-Other |
8.659400E-01 |
| Follicular-VS-Normal |
1.835030E-04 |
| Other-VS-Normal |
5.404200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.68220000000319E-05 |
| Normal-vs-N1 |
9.842100E-03 |
| N0-vs-N1 |
3.999000E-01 |
|
|
